Navigation Links
Endologix Announces Favorable Markman Ruling in Cook Patent Litigation

IRVINE, Calif., Aug. 17, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that Judge Tanya Walton Pratt of the United States District Court for the Southern District of Indiana in Indianapolis has issued a Markman ruling in the ongoing patent infringement lawsuit filed against the Company by Cook Medical.

In a Markman ruling, the court determines the meaning of disputed patent claim terms at issue in patent litigation.  After a briefing and oral argument on April 15, 2011 as to the meaning of a number of terms of the claims of the two patents that Cook is asserting in the lawsuit, Judge Pratt adopted many of Endologix's proposed constructions for several terms of claims of both asserted patents, including constructions that the Company considers to be important for the outcome of the case.

The trial date for the patent infringement lawsuit has not yet been set but is expected to be set for fall 2012.

John McDermott, President and Chief Executive Officer of Endologix, commented, "We are pleased with the results of the Markman hearing, remain confident in our position going forward and intend to continue to pursue our numerous defenses."

About Endologix, Inc.Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at

Forward-Looking Statements Except for historical information contained herein, this news release contains forward-looking statements relating to the continuing litigation with Cook Medical.   The achievement of the plans and objectives in such statements involves risks and uncertainties including, but not limited to, risks and uncertainties related to the costs and outcome of intellectual property litigation, many of which are difficult or impossible to predict accurately and many of which are beyond the control of Endologix. The Company undertakes no obligation to update its forward looking statements. Please refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2010, and the Company's other filings with the Securities and Exchange Commission, for more detailed information regarding these risks and other factors that may cause actual results to differ materially from those expressed or implied.COMPANY CONTACT:


The Ruth GroupJohn McDermott, CEO

Nick Laudico (646) 536-7030(949) 595-7200

Zack Kubow (646)

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endologix Announces First U.S. Implant of AFX™ Endovascular AAA System
2. Endologix to Present at Two Upcoming Conferences
3. Endologix Reports 22% Second Quarter 2011 Revenue Growth
4. Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products
5. Endologix to Report Second Quarter 2011 Financial Results on July 21, 2011
6. Endologix Announces FDA Approval of AFX™ Endovascular AAA System
7. Endologix to Present at the 2011 Bank of America Merrill Lynch Health Care Conference
8. Endologix Files Form 10-K; Nellix Purchase Price Allocation Finalized
9. Endologix to Present at the ROTH 23rd Annual OC Growth Stock Conference
10. Endologix Reports 41% Fourth Quarter 2010 Revenue Growth
11. Endologix Announces Presentation of Favorable Initial PEVAR Trial Results
Post Your Comments:
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... is actively feeding the Frederick area economy by obtaining investment capital for emerging ... the past 2½ years that have already resulted in more than a million ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):